Fresh2 Group Limited American Depositary Shares

FRES

...

FRES: Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

Show FRES Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of FRES by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by FRES's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on FRES's company Twitter account

WallStreetBets

Number of mentions of FRES in WallStreetBets Daily Discussion

FRES News

Recent insights relating to FRES

CNBC Recommendations

Recent picks made for FRES stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in FRES

Corporate Flights

Flights by private jets registered to FRES